These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1216 related items for PubMed ID: 20380584
1. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction. Gomez AM, Van Den Broeck J, Vrolix K, Janssen SP, Lemmens MA, Van Der Esch E, Duimel H, Frederik P, Molenaar PC, Martínez-Martínez P, De Baets MH, Losen M. Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584 [Abstract] [Full Text] [Related]
3. The auto-antigen repertoire in myasthenia gravis. Vrolix K, Fraussen J, Molenaar PC, Losen M, Somers V, Stinissen P, De Baets MH, Martínez-Martínez P. Autoimmunity; 2010 Aug; 43(5-6):380-400. PubMed ID: 20380581 [Abstract] [Full Text] [Related]
4. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects. Viegas S, Jacobson L, Waters P, Cossins J, Jacob S, Leite MI, Webster R, Vincent A. Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541 [Abstract] [Full Text] [Related]
5. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638 [Abstract] [Full Text] [Related]
14. Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis. Mori S, Shigemoto K. Autoimmun Rev; 2013 Jul; 12(9):912-7. PubMed ID: 23537506 [Abstract] [Full Text] [Related]
15. Induction of myasthenia by immunization against muscle-specific kinase. Shigemoto K, Kubo S, Maruyama N, Hato N, Yamada H, Jie C, Kobayashi N, Mominoki K, Abe Y, Ueda N, Matsuda S. J Clin Invest; 2006 Apr; 116(4):1016-24. PubMed ID: 16557298 [Abstract] [Full Text] [Related]
16. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Higuchi O, Hamuro J, Motomura M, Yamanashi Y. Ann Neurol; 2011 Feb; 69(2):418-22. PubMed ID: 21387385 [Abstract] [Full Text] [Related]
18. [Pathogenic antibodies in myasthenia gravis]. Motomura M. Brain Nerve; 2010 Apr; 62(4):411-8. PubMed ID: 20420182 [Abstract] [Full Text] [Related]
19. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis. Deymeer F, Gungor-Tuncer O, Yilmaz V, Parman Y, Serdaroglu P, Ozdemir C, Vincent A, Saruhan-Direskeneli G. Neurology; 2007 Feb 20; 68(8):609-11. PubMed ID: 17310034 [Abstract] [Full Text] [Related]
20. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Shiraishi H, Motomura M, Yoshimura T, Fukudome T, Fukuda T, Nakao Y, Tsujihata M, Vincent A, Eguchi K. Ann Neurol; 2005 Feb 20; 57(2):289-93. PubMed ID: 15668981 [Abstract] [Full Text] [Related] Page: [Next] [New Search]